- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2019–2024 · career development · K08
The roles of anti-apoptotic proteins BCL-XL and MCL1 in mediating survival of high-grade serous ovarian cancer following drug-induced DNA damage
Elizabeth Harmon Stover · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · fellowship · Banting Postdoctoral Fellowship Program
The contribution of germline variants to somatic EGFR mutation risk in lung adenocarcinoma in the Latin American populations.
Jian Carrot-Zhang · Dana-Farber Cancer Institute · funded by Canadian Institutes of Health Research
2019–2026 · research · R35
Targeting High-Risk Lymphoid Neoplasms
David Marc Weinstock · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · grant · KCRP
Functionally Characterizing the Enhancer Cistrome in Advanced Human Kidney Cancer
Mark Pomerantz · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2023 · research · R01
Incomplete Penetrance via Edgetic Suppression
Michael A Calderwood · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · career development · K08
Expectations for Pediatric Cancer Treatment (EXPECT): A Family-Centered Intervention to Prepare Parents for Pediatric Leukemia Therapy
Katie A. Greenzang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · research · R01
Genetic dissection of visceral pain pathways
Qiufu Ma · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Defining mechanisms of succinate regulation over adipose tissue thermogenesis
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Novel Screening Platform for Discovery of DUB Targeting Probes
Sara J Buhrlage · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2020 · fellowship · F32
Investigating the Mesenchymal Component of the Intestinal Stem Cell Niche.
Neil Mccarthy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Harold John Burstein · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2028 · research · R01
Defining mechanisms of extracellular succinate regulation over metabolic tissue function
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · research · R01
The Function of CDK5 in Metastasis
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · career development · K08
Mechanistic Determinants of Follicular-Helper T-cell Lymphomagenesis
Samuel Yao-Ming Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · career development · K00
Effects of Extracellular Mechanics on Mechanosensory and Central Neuron Function
Joy Ann Franco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Small molecules targeting hepatic glucose production and insulin resistance
Patrick Robert Griffin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Cellular and molecular characterization of the digestive tract sub-epithelium
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019 · award
Targeting the nuclear export factor NXT1 in neuroblastoma
Clare Malone · Dana-Farber Cancer Institute · funded by American Cancer Society
2019–2023 · research · R01
Control of PGC1alpha Translation and Function
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Small molecules targeting hepatic glucose production and insulin resistance
Patrick Robert Griffin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R35
Data Analysis Tools for Emerging High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · training · T32
Cancer Chemical Biology and Metabolism Training Program
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · grant · PRCRP
Targeting Pediatric Fusion Oncoproteins via Protein Degradation
Bo Kyung Seong · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2021 · fellowship · F32
Mechanism of activation of a new cGAS-like enzyme in humans
Benjamin Robert Morehouse · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2020 · research · R21
Strengthening Patient and Caregiver Supports in Ovarian Cancer with Palliative Care: Pilot RCT of BOLSTER
Alexi A Wright · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface
Mikyung Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · research · R21
Passive Data to Improve Outcomes in Advanced Cancer
Jukka-Pekka Onnela · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R35
Data Analysis Tools for Emerging High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
Wilfred Ngwa · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Cellular and molecular characterization of the digestive tract sub-epithelium
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2027 · research · R01
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R50
Validation of EP400 downstream effectors and potential therapeutic targets in Merkel cell carcinoma
Jingwei Cheng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
The Function of CDK5 in Metastasis
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Immune Modulation After Allogeneic HCT
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
